LIVZON PHARMA (01513) has announced its intention to distribute a special interim dividend, offering shareholders a return amid steady financial performance and robust cash reserves.

For the first half of 2026, the company maintained a healthy operational status and solid profitability. Its accumulated undistributed profits remain at a relatively high level, supported by ample monetary resources and a stable asset-liability structure. The existing funds are sufficient to cover research and development expenditures alongside day-to-day operational needs.

To express gratitude for the long-standing trust and support from all shareholders, the board of directors has resolved to propose a special interim dividend of RMB 10.20 per ten shares (inclusive of tax). This translates to an aggregate special interim dividend payout of approximately RMB 906 million (inclusive of tax).